CR MEDICAL released its interim results, with shareholders' profit attributable to them at HKD 340 million, a year-on-year decrease of 21.76%
CR MEDICAL released its interim results for the period ending June 30, 2025, with revenue of CNY 4.525 billion, a year-on-year decrease of 9.07%; profit attributable to shareholders was CNY 340 million, a year-on-year decrease of 21.76%. The basic earnings per share were CNY 0.27, and an interim dividend of CNY 0.05 per share is proposed. The hospital business segment's revenue was CNY 4.259 billion, a year-on-year decrease of 7.4%. The group manages a total of 103 medical institutions across 10 provinces and cities in China
According to the Zhitong Finance APP, CR MEDICAL (01515) released its interim results for the six months ending June 30, 2025, with revenue of RMB 4.525 billion, a year-on-year decrease of 9.07%; profit attributable to shareholders of RMB 340 million, a year-on-year decrease of 21.76%; basic earnings per share of RMB 0.27; and a proposed interim dividend of 5 cents per share.
The announcement stated that during the reporting period, the hospital business segment's revenue was RMB 4.259 billion, a year-on-year decrease of 7.4%. Among them, the number of outpatient and emergency visits increased by 1.0%, while the number of inpatient visits decreased by 3.9%; due to a decline in average medical insurance costs, the average revenue per outpatient and inpatient visit decreased by 5.8% each.
As of June 30, 2025, the group managed and operated 103 medical institutions across 10 provinces and cities in China. During the reporting period, the group's own hospitals had approximately 5.1 million outpatient and emergency visits and 270,000 inpatient visits, representing a year-on-year increase of 1.0% and a decrease of 3.9%, respectively
